Health Care & Life Sciences » Pharmaceuticals | Zeria Pharmaceutical Co. Ltd.

Zeria Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
22,202
18,012
12,343
9,351
10,174
8,045
Total Accounts Receivable
15,485
16,241
14,764
16,620
15,591
14,911
Inventories
7,734
8,189
8,013
8,609
9,376
10,024
Other Current Assets
4,481
3,238
4,575
4,185
4,115
5,743
Total Current Assets
49,902
45,681
39,695
38,765
39,256
38,723
Net Property, Plant & Equipment
21,953
22,021
23,274
24,154
23,341
22,914
Total Investments and Advances
10,497
9,687
12,428
9,165
6,936
5,538
Intangible Assets
13,251
12,345
35,784
33,885
32,338
29,799
Other Assets
3,153
6,450
7,984
8,357
14,190
13,415
Total Assets
99,494
96,268
119,178
114,358
116,086
110,434
ST Debt & Current Portion LT Debt
12,594
11,573
39,038
33,062
24,926
Accounts Payable
3,718
2,384
2,041
2,273
2,073
Income Tax Payable
1,999
1,177
504
554
694
Other Current Liabilities
7,642
6,777
6,663
9,290
8,467
Total Current Liabilities
25,953
21,911
48,246
45,178
36,160
Long-Term Debt
13,867
10,636
4,654
2,884
8,676
Provision for Risks & Charges
228
446
719
812
806
Deferred Taxes
218
430
1,284
1,753
4,483
Other Liabilities
190
189
195
195
240
Total Liabilities
40,759
33,698
55,111
50,853
50,390
Common Equity (Total)
58,735
62,571
63,735
63,352
65,532
Total Shareholders' Equity
58,735
62,571
63,735
63,352
65,532
Total Equity
58,735
62,571
64,067
63,505
65,696
Liabilities & Shareholders' Equity
99,494
96,268
119,178
114,358
116,086
Accumulated Minority Interest
-
-
332
153
164

About Zeria Pharmaceutical Co.

View Profile
Address
10-11 Nihonbashi Kobuna-cho
Tokyo Tokyo 103
Japan
Employees -
Website http://www.zeria.co.jp
Updated 07/08/2019
Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. It also develops and distributes agricultural and industrial chemicals, and reagents. It operates through the following segments: Ethical Pharmaceuticals, Consumer Healthcare, and Others.